StarDrop, is an integrated software package deployed by pharmaceutical and biotech companies to support their drug discovery programs. StarDrop’s integration of the libraries and toolkits developed by OpenEye Scientific, including OEChem, OEDepict and OMEGA, enables accelerated development of Optibrium’s in silico drug discovery technologies and artificial intelligence services.
OpenEye Scientific is an industry leader in the field of cheminformatics software for drug discovery, providing high-performance and robust libraries with a developer-friendly Application Programming Interface, supporting the development of highly customisable software solutions and workflows. The company directly supports pharmaceutical and biotechnology companies as well as making its cheminformatics platform available to software companies, such as Optibrium, enabling high-performance cheminformatics software solutions.
Dr Matthew Segall, Optibrium’s CEO, said: 'We continue to invest in cutting-edge research to deliver high-quality science and new functionality that is accessible within StarDrop’s intuitive user interface, to the benefit of our global user base. We highly value this collaboration with OpenEye Scientific, a company that shares our commitment to creating best-in-class technologies designed for reliability and performance.'
The companies continue to work closely together to leverage future opportunities to advance their respective platforms.
